Stock Research for MNTA

MNTA

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

MNTA Stock Chart & Research Data

The MNTA chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the MNTA chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


MNTA Due diligence Resources & Stock Charts

The MNTA stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View MNTA Detailed Price Forecast - CNN Money CNN View MNTA Detailed Summary - Google Finance
Yahoo View MNTA Detailed Summary - Yahoo! Finance Zacks View MNTA Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View MNTA Trends & Analysis - Trade-Ideas Barrons View MNTA Major Holders - Barrons
NASDAQ View MNTA Call Transcripts - NASDAQ Seeking View MNTA Breaking News & Analysis - Seeking Alpha
Spotlight View MNTA Annual Report - CompanySpotlight.com OTC Report View MNTA OTC Short Report - OTCShortReport.com
TradeKing View MNTA Fundamentals - TradeKing Charts View MNTA SEC Filings - Bar Chart
WSJ View Historical Prices for MNTA - The WSJ Morningstar View Performance/Total Return for MNTA - Morningstar
MarketWatch View the Analyst Estimates for MNTA - MarketWatch CNBC View the Earnings History for MNTA - CNBC
StockMarketWatch View the MNTA Earnings - StockMarketWatch MacroAxis View MNTA Buy or Sell Recommendations - MacroAxis
Bullish View the MNTA Bullish Patterns - American Bulls Short Pains View MNTA Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View MNTA Stock Mentions - StockTwits PennyStocks View MNTA Stock Mentions - PennyStockTweets
Twitter View MNTA Stock Mentions - Twitter Invest Hub View MNTA Investment Forum News - Investor Hub
Yahoo View MNTA Stock Mentions - Yahoo! Message Board Seeking Alpha View MNTA Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for MNTA - SECform4.com Insider Cow View Insider Transactions for MNTA - Insider Cow
CNBC View MNTA Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for MNTA - OTC Markets
Yahoo View Insider Transactions for MNTA - Yahoo! Finance NASDAQ View Institutional Holdings for MNTA - NASDAQ


Stock Charts

FinViz View MNTA Stock Insight & Charts - FinViz.com StockCharts View MNTA Investment Charts - StockCharts.com
BarChart View MNTA Stock Overview & Charts - BarChart Trading View View MNTA User Generated Charts - Trading View




Latest Financial News for MNTA


Here's Why Momenta Pharmaceuticals Jumped 18% on Friday
Posted on Friday December 07, 2018

Investors are excited about all the capital the biotech raised.


The Daily Biotech Pulse: FDA Nod For Roche, Bristol-Myers Hikes Dividend, 2 Biotechs To Debut
Posted on Friday December 07, 2018

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech stocks hitting 52-week highs on Dec. 6) Gritstone Oncology Inc (NASDAQ: GRTS ) Down In The Dumps ...


Momenta Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Posted on Thursday December 06, 2018

Momenta Pharmaceuticals, Inc. (MNTA), a biotechnology company with a validated scientific platform focused on discovering and developing novel therapeutics to treat rare, immune-mediated diseases, today announced the pricing of its underwritten public offering of 17,391,305 shares of its common stock at the public offering price of $11.50 per share. The offering is being made pursuant to an effective shelf registration statement on Form S-3 that was initially filed with the U.S. Securities and Exchange Commission (SEC) on February 29, 2016. A preliminary prospectus supplement describing the terms of the offering has been filed with the SEC and forms a part of the effective registration statement.  A final prospectus supplement will be filed with the SEC and will form a part of the effective registration statement.


See what the IHS Markit Score report has to say about Momenta Pharmaceuticals Inc.
Posted on Thursday December 06, 2018

Momenta Pharmaceuticals Inc NASDAQ/NGS:MNTA


Stock Market & Investing Books

Enter a stock symbol to view the stock details.